Hear from executives and R&D leaders who were instrumental in partnering and acquiring new technologies at Sanofi-Genzyme, Millennium-Takeda, Pfizer and Biogen, and are now on the ‘other side of the table’ working for biotech companies. These leaders will share their insights for the characteristics of discovery platforms, technologies and drug candidates that are attractive for industry collaborations with larger drug partners. Each of the panelists has chosen to move from a larger company to now work in a biotech environment, where they can drive innovation in drug development. By sharing their insights from both vantage points – larger and smaller companies – they offer ideas for collaboration strategies.

Ability Level: All

Session ID: 21205